NPHSL proposal for HERA 2 (EU4H-2022-DGA-MS-IBA-01-02)
- Funded by European Commission
- Total publications:0 publications
Grant number: 101112981
Grant search
Key facts
Disease
COVID-19, Disease XStart & end year
20232025Known Financial Commitments (USD)
$1,089,638.12Funder
European CommissionPrincipal Investigator
Griškevičius AlgirdasResearch Location
LithuaniaLead Research Institution
NACIONALINE VISUOMENES SVEIKATOS PRIEZIUROS LABORATORIJAResearch Priority Alignment
N/A
Research Category
14
Research Subcategory
N/A
Special Interest Tags
Data Management and Data SharingInnovation
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
C/WGS project'Äôs aim is to enhance existing WGS technologies and their capacity to respond not only to new emerging SARS-Cov-2 variants, but also to other pathogens of concern in Lithuania. This project is the continuation of previous project Grant/2021/PHF/23776 and ensures the support and extension of previously implemented technologies. Significant objectives of this project would be: the use of existing technologies for implementation of new assays, improving previously implemented integration systems and initiation of new integration systems for other than SARS-CoV-2 pathogens; sustainable workflow optimization, further personnel training and increasing the visibility of the project to the public.